To further investigate the relationship between the HES1 promoter variant and the risk of CHD development, we then recruited an additional 629 sporadic non-syndromic CHD cases and 696 healthy controls and performed direct Sanger sequencing of the HES1 promoter to identify heterozygous and homozygous variants. This evidence concerns the gene HES1 and coronary artery disorder.